Literature DB >> 2868897

Reliability of adverse drug reaction assessment in psychiatric inpatients.

R Grohmann, P Dirschedl, J Scherer, L G Schmidt, O Wunderlich.   

Abstract

Within an ongoing drug surveillance program in psychiatric hospitals the applicability of an algorithm for judgment on probability of causal relationship of adverse events and drug therapy was tested. Algorithmic interrater agreement was compared to agreement obtained with the conventional criteria used so far within the program in 80 cases by two raters, who had participated in the drug surveillance program since its beginning in 1979. With the use of the algorithm raters agreed on imputed drugs in 86% of all cases; total agreement on drugs and degree of probability was obtained in 69% (weighted kappa 0.618). Raters agreed on total score for the imputed medication in 49% and also on all subscores for the different axes of the algorithm in 43% of all cases. Differentiation of drug-related from illness-related changes, the use of judgmental terms within the algorithm and specific problems created by the frequent use of combinations of drugs with similar profiles of adverse drug reactions (ADR) in psychiatric patients were identified as the main sources of disagreement. Agreement on total judgment was comparable to results from similar studies in the literature using various algorithms, but in contrast to all these studies a higher percent of agreement (80%) was obtained with the use of the conventional criteria in this study.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2868897     DOI: 10.1007/bf00380987

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  25 in total

1.  Adverse drug reactions. A critical review.

Authors:  F E Karch; L Lasagna
Journal:  JAMA       Date:  1975-12-22       Impact factor: 56.272

2.  Antipsychotic drug use: physician prescribing practices in relation to current recommendations.

Authors:  N H Schroeder; E M Caffey; T W Lorei
Journal:  Dis Nerv Syst       Date:  1977-02

3.  The ambiguity of adverse drug reactions.

Authors:  J Koch-Weser; E M Sellers; R Zacest
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

4.  Reasons for disagreement in the standardized assessment of suspected adverse drug reactions.

Authors:  T A Hutchinson; K M Flegel; H HoPingKong; W S Bloom; M S Kramer; E G Trummer
Journal:  Clin Pharmacol Ther       Date:  1983-10       Impact factor: 6.875

5.  [Mehtod for determination of undesirable effects of drugs].

Authors:  J Dangoumau; J C Evreux; J Jouglard
Journal:  Therapie       Date:  1978 May-Jun       Impact factor: 2.070

6.  [Determination of undesirable effects of drugs. Study of 194 case reports].

Authors:  B Begaud; A Boisseau; H Albin; J Dangoumau
Journal:  Therapie       Date:  1978 May-Jun       Impact factor: 2.070

7.  Comparison of two recently published algorithms for assessing the probability of adverse drug reactions.

Authors:  U Busto; C A Naranjo; E M Sellers
Journal:  Br J Clin Pharmacol       Date:  1982-02       Impact factor: 4.335

8.  [Methods for studying the adverse effects of drugs. II. Profile and comparison of 5 methods for establishing causality].

Authors:  J C Péré; B Bégaud; F Haramburu; H Albin
Journal:  Therapie       Date:  1984 Jul-Aug       Impact factor: 2.070

9.  [Establishing a criteria: the bibliography (author's transl)].

Authors:  B Begaud; J C Pere; J Dangoumau
Journal:  Therapie       Date:  1981 May-Jun       Impact factor: 2.070

10.  An algorithm for the operational assessment of adverse drug reactions. III. Results of tests among clinicians.

Authors:  J M Leventhal; T A Hutchinson; M S Kramer; A R Feinstein
Journal:  JAMA       Date:  1979-11-02       Impact factor: 56.272

View more
  1 in total

1.  Consistency of assessment of adverse drug reactions in psychiatric hospitals: a comparison of an algorithmic and an empirical approach.

Authors:  L G Schmidt; P Dirschedl; R Grohmann; J Scherer; O Wunderlich; B Müller-Oerlinghausen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.